Giulia Morsica

Summary

Affiliation: San Raffaele Scientific Institute
Country: Italy

Publications

  1. pmc Virological pattern of hepatitis B infection in an HIV-positive man with fatal fulminant hepatitis B: a case report
    Sabrina Bagaglio
    Infectious Diseases Department, San Raffaele, Scientific Institute, via Stamira D Ancona, Milano 20127, Italy
    J Med Case Reports 3:110. 2009
  2. ncbi request reprint Hepatitis C virus (HCV) coinfection in a cohort of HIV positive long-term non-progressors: possible protective effect of infecting HCV genotype on HIV disease progression
    Giulia Morsica
    Division of Infectious Diseases, San Raffaele, Scientific Institute, via Stamira d Ancona n 20, 20127 Milan, Italy
    J Clin Virol 39:82-6. 2007
  3. ncbi request reprint Hepatic safety profile of darunavir with low-dose ritonavir (DRV/r) in HIV/HCV coinfected and HIV monoinfected patients
    Giulia Morsica
    Department of Infectious Diseases, San Raffaele, Scientific Institute, Milan, Italy
    New Microbiol 34:317-21. 2011
  4. doi request reprint Occult hepatitis B virus infection in a cohort of HIV-positive patients: correlation with hepatitis C virus coinfection, virological and immunological features
    G Morsica
    Dept of Infectious Diseases, S Raffaele Scientific Institute, Milan, Italy
    Infection 37:445-9. 2009
  5. doi request reprint Viral interference between hepatitis B, C, and D viruses in dual and triple infections in HIV-positive patients
    Giulia Morsica
    Department of Infectious Diseases, San Raffaele, Scientific Institute, Milan, Italy
    J Acquir Immune Defic Syndr 51:574-81. 2009
  6. ncbi request reprint Naive HIV/HCV-coinfected patients have higher intrahepatic pro-inflammatory cytokines than coinfected patients treated with antiretroviral therapy
    Giovanni Sitia
    Infectious Disease Department, San Raffaele Scientific Institute, Milan, Italy
    Antivir Ther 11:385-9. 2006
  7. ncbi request reprint Hepatitis C virus populations in the plasma, peripheral blood mononuclear cells and cerebrospinal fluid of HIV/hepatitis C virus-co-infected patients
    Sabrina Bagaglio
    Department of Infectious Diseases, San Raffaele Scientific Institute, Milan, Italy
    AIDS 19:S151-65. 2005
  8. ncbi request reprint HAART simplification with lopinavir/ritonavir monotherapy in HIV/HCV co-infected patients starting anti-HCV treatment: a randomised pilot study (KaMon study)
    Hamid Hasson
    Department of Infectious Diseases, IRCCS Ospedale San Raffaele, Milan, Italy
    New Microbiol 35:469-74. 2012
  9. doi request reprint Non-invasive fibrosis biomarkers - APRI and Forns - are associated with liver stiffness in HIV-monoinfected patients receiving antiretroviral drugs
    Hamid Hasson
    Department of Infectious Diseases, IRCCS Ospedale San Raffaele, Milan, Italy
    Liver Int 33:1113-20. 2013
  10. ncbi request reprint Pretreatment of chronic active hepatitis C in patients coinfected with HIV and hepatitis C virus reduces the hepatotoxicity associated with subsequent antiretroviral therapy
    Caterina Uberti-Foppa
    Department of Infectious Diseases, Vita Salute San Raffaele University, Via Stamira d Ancona 20, 20127 Milan, Italy
    J Acquir Immune Defic Syndr 33:146-52. 2003

Detail Information

Publications17

  1. pmc Virological pattern of hepatitis B infection in an HIV-positive man with fatal fulminant hepatitis B: a case report
    Sabrina Bagaglio
    Infectious Diseases Department, San Raffaele, Scientific Institute, via Stamira D Ancona, Milano 20127, Italy
    J Med Case Reports 3:110. 2009
    ..There seem to be no published data concerning the clinical impact of populations of hepatitis B virus (HBV) in the hepatic and extrahepatic compartments of HIV-infected people with severe acute hepatitis...
  2. ncbi request reprint Hepatitis C virus (HCV) coinfection in a cohort of HIV positive long-term non-progressors: possible protective effect of infecting HCV genotype on HIV disease progression
    Giulia Morsica
    Division of Infectious Diseases, San Raffaele, Scientific Institute, via Stamira d Ancona n 20, 20127 Milan, Italy
    J Clin Virol 39:82-6. 2007
    ..Hepatitis C virus (HCV) infection is frequent in HIV-positive subjects. We evaluated the potential impact of HCV coinfection and other determinants on HIV disease progression in a cohort of long-term non-progressors (LTNPs)...
  3. ncbi request reprint Hepatic safety profile of darunavir with low-dose ritonavir (DRV/r) in HIV/HCV coinfected and HIV monoinfected patients
    Giulia Morsica
    Department of Infectious Diseases, San Raffaele, Scientific Institute, Milan, Italy
    New Microbiol 34:317-21. 2011
    ..6xULN. This study showed evidence of long-lasting hepatic safety of ART including PI DRV/r in HIV/HCV coinfected and in HIV monoinfected persons...
  4. doi request reprint Occult hepatitis B virus infection in a cohort of HIV-positive patients: correlation with hepatitis C virus coinfection, virological and immunological features
    G Morsica
    Dept of Infectious Diseases, S Raffaele Scientific Institute, Milan, Italy
    Infection 37:445-9. 2009
    ..An evaluation of the prevalence of occult hepatitis B virus (HBV) infection in HIV-positive individuals is important as HBV infection may have an impact on the outcome of the liver disease in these patients...
  5. doi request reprint Viral interference between hepatitis B, C, and D viruses in dual and triple infections in HIV-positive patients
    Giulia Morsica
    Department of Infectious Diseases, San Raffaele, Scientific Institute, Milan, Italy
    J Acquir Immune Defic Syndr 51:574-81. 2009
    ..To investigate the reciprocal inhibitory effects of hepatitis B virus (HBV)/hepatitis C virus (HCV)/hepatitis D virus (HDV) infections in naive and previously antiretroviral-experienced HIV-positive patients...
  6. ncbi request reprint Naive HIV/HCV-coinfected patients have higher intrahepatic pro-inflammatory cytokines than coinfected patients treated with antiretroviral therapy
    Giovanni Sitia
    Infectious Disease Department, San Raffaele Scientific Institute, Milan, Italy
    Antivir Ther 11:385-9. 2006
    ..Together, these results suggest that HIV infection may exacerbate the immune-mediated inflammatory response in the liver of patients chronically infected with HCV and antiretroviral therapy may prevent this effect...
  7. ncbi request reprint Hepatitis C virus populations in the plasma, peripheral blood mononuclear cells and cerebrospinal fluid of HIV/hepatitis C virus-co-infected patients
    Sabrina Bagaglio
    Department of Infectious Diseases, San Raffaele Scientific Institute, Milan, Italy
    AIDS 19:S151-65. 2005
    ..Chronic hepatitis C virus (HCV) infection has occasionally been associated with diseases of the central nervous system, thus suggesting that the virus has a direct effect on cerebral function...
  8. ncbi request reprint HAART simplification with lopinavir/ritonavir monotherapy in HIV/HCV co-infected patients starting anti-HCV treatment: a randomised pilot study (KaMon study)
    Hamid Hasson
    Department of Infectious Diseases, IRCCS Ospedale San Raffaele, Milan, Italy
    New Microbiol 35:469-74. 2012
    ..146). No HIV failure was observed. The safety profile of LPV/r monotherapy was similar to that of LPV/r´┐Żbased HAART, thus encouraging HAART simplification in patients receiving anti-HCV treatment...
  9. doi request reprint Non-invasive fibrosis biomarkers - APRI and Forns - are associated with liver stiffness in HIV-monoinfected patients receiving antiretroviral drugs
    Hamid Hasson
    Department of Infectious Diseases, IRCCS Ospedale San Raffaele, Milan, Italy
    Liver Int 33:1113-20. 2013
    ....
  10. ncbi request reprint Pretreatment of chronic active hepatitis C in patients coinfected with HIV and hepatitis C virus reduces the hepatotoxicity associated with subsequent antiretroviral therapy
    Caterina Uberti-Foppa
    Department of Infectious Diseases, Vita Salute San Raffaele University, Via Stamira d Ancona 20, 20127 Milan, Italy
    J Acquir Immune Defic Syndr 33:146-52. 2003
    ..The authors also confirm that the baseline level of ALT is an important prognostic factor for increased liver damage during antiretroviral therapy...
  11. doi request reprint Surgical site infections in HIV-infected patients: results from an Italian prospective multicenter observational study
    C M J Drapeau
    2nd Infectious Diseases Division, National Institute for Infectious Diseases, L Spallanzani, Via Portuense 292, 00149, Rome, Italy
    Infection 37:455-60. 2009
    ..The aim of this study was to determine the incidence and the associated risk factors for SSI in HIV-infected patients...
  12. ncbi request reprint Evolution of hepatitis C virus non-structural 5A gene in the progression of liver disease to hepatocellular carcinoma
    Maria Stella De Mitri
    Department of Internal Medicine, Cardioangiology, Hepatology, University of Bologna, Bologna, Italy
    Liver Int 27:1126-33. 2007
    ....
  13. ncbi request reprint Comparison of IFN-alpha 2b with or without ribavirin for treatment of chronic hepatitis C in HIV-positive patients infected with hepatitis C virus genotype 3a
    Giulia Morsica
    AIDS 18:1080-2. 2004
  14. ncbi request reprint Chronic hepatitis B in children after e antigen seroclearance: final report of a 29-year longitudinal study
    Flavia Bortolotti
    Fifth Medical Clinic, University of Padova, Italy
    Hepatology 43:556-62. 2006
    ..Long-term monitoring is important, as is counseling on cofactors of liver damage, such as alcohol and drug abuse...
  15. ncbi request reprint The appropriate method of evaluating the dynamics of hepatitis B virus in patients receiving antiviral treatment: the other side of the coin
    Giulia Morsica
    AIDS 19:1933-4. 2005
  16. ncbi request reprint Response to HAART and GB virus type C coinfection in a cohort of antiretroviral-naive HIV-infected individuals
    Giorgio Antonucci
    National Institute of Infectious Diseases, L Spallanzani, Roma, Italy
    Antivir Ther 10:109-17. 2005
    ..These results suggest that GBV-C coinfection may play a role in determining the rate of HIV rebound possibly by competing with HIV replication after HIV load has been successfully suppressed by HAART...
  17. ncbi request reprint Prevalence of wild-type in NS5A-PKR protein kinase binding domain in HCV-related hepatocellular carcinoma
    Maria Stella De Mitri
    Department of Internal Medicine, Cardioangiology, Hepatology, University of Bologna, Bologna, Italy
    J Hepatol 36:116-22. 2002
    ..In 13 HCC cases sequence analysis was also performed in tumor and nontumor liver tissues...